- Home
- IMVT vs PAYO Comparison
IMVT vs PAYO Comparison
Compare IMVT & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- PAYO
- Stock Information
- Founded
- IMVT 2018
- PAYO 2005
- Country
- IMVT United States
- PAYO United States
- Employees
- IMVT N/A
- PAYO N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- PAYO EDP Services
- Sector
- IMVT Health Care
- PAYO Technology
- Exchange
- IMVT Nasdaq
- PAYO Nasdaq
- Market Cap
- IMVT 2.7B
- PAYO 2.5B
- IPO Year
- IMVT N/A
- PAYO N/A
- Fundamental
- Price
- IMVT $16.08
- PAYO $6.57
- Analyst Decision
- IMVT Buy
- PAYO Strong Buy
- Analyst Count
- IMVT 11
- PAYO 8
- Target Price
- IMVT $37.38
- PAYO $9.81
- AVG Volume (30 Days)
- IMVT 1.3M
- PAYO 2.3M
- Earning Date
- IMVT 08-08-2025
- PAYO 08-06-2025
- Dividend Yield
- IMVT N/A
- PAYO N/A
- EPS Growth
- IMVT N/A
- PAYO N/A
- EPS
- IMVT N/A
- PAYO 0.28
- Revenue
- IMVT N/A
- PAYO $996,150,000.00
- Revenue This Year
- IMVT N/A
- PAYO $4.94
- Revenue Next Year
- IMVT N/A
- PAYO $5.85
- P/E Ratio
- IMVT N/A
- PAYO $23.39
- Revenue Growth
- IMVT N/A
- PAYO 14.86
- 52 Week Low
- IMVT $12.72
- PAYO $5.03
- 52 Week High
- IMVT $34.47
- PAYO $11.29
- Technical
- Relative Strength Index (RSI)
- IMVT 41.15
- PAYO 43.68
- Support Level
- IMVT $15.31
- PAYO $6.69
- Resistance Level
- IMVT $17.12
- PAYO $6.79
- Average True Range (ATR)
- IMVT 0.84
- PAYO 0.20
- MACD
- IMVT -0.27
- PAYO -0.02
- Stochastic Oscillator
- IMVT 20.53
- PAYO 21.62
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.